dmuc4064a
mAbexperimentalADC
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 22, 2014 (NCT02146313)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Mucin-16INHIBITOR
MUC16 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- Monomethylauristatin E
Oral
No
Parenteral
No
Topical
No
Also known as
- dmuc4064a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02146313 | Phase 1 | Jun 22, 2014 | Genentech, Roche |
Showing 1 of 1 trials
Page 1 / 1